Close Menu

Lund University

Research reported at the AACR annual meeting suggests mutations in the estrogen receptor gene ESR1 in untreated primary breast cancers can influence endocrine treatment response.

Three new studies have found that the presence of B cells in tertiary lymphoid structures in tumors is associated with a favorable response to immunotherapy.